Saltar al contenido

Charles River Laboratories International, Inc. (CRL) stock: revenue, earnings & dividend

Charles River Laboratories International, Inc. (CRL, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener CRL · NYSE Dienstleistungen US-MA

Key figures

Fiscal year
2025
Revenue
4.02 bn $
Revenue growth
-0.9 %
Revenue growth 5y (p.a.)
6.6 %
Net income
-144.34 m $
Net margin
-3.6 %
Operating margin
0.6 %
Earnings per share (diluted)
-2.91 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
7.14 bn $
Equity
3.16 bn $
Equity ratio
44.4 %
Return on equity
-4.6 %
Cash
214 m $
Operating cash flow
738 m $
Free cash flow
–
Shares outstanding
47,917,467

History

Revenue by fiscal year

2016 1.68 bn $
2017 1.86 bn $
2018 2.27 bn $
2019 2.62 bn $
2020 2.92 bn $
2021 3.54 bn $
2022 3.98 bn $
2023 4.13 bn $
2024 4.05 bn $
2025 4.02 bn $

Net income by fiscal year

2016 155 m $
2017 123 m $
2018 226 m $
2019 252 m $
2020 364 m $
2021 391 m $
2022 486 m $
2023 475 m $
2024 22.2 m $
2025 -144.34 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20254.02 bn $-144.34 m $-2.91 $–738 m $
20244.05 bn $22.2 m $0.20 $–735 m $
20234.13 bn $475 m $9.22 $–684 m $
20223.98 bn $486 m $9.48 $–620 m $
20213.54 bn $391 m $7.60 $–761 m $
20202.92 bn $364 m $7.20 $–547 m $
20192.62 bn $252 m $5.07 $–481 m $
20182.27 bn $226 m $4.62 $–441 m $
20171.86 bn $123 m $2.54 $–318 m $
20161.68 bn $155 m $3.23 $–317 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)